tiprankstipranks

Paul Sandland Insider Profile

4 Followers
Paul Sandland, Chief Financial Officer at Dechra Pharmaceuticals, holds 6.52K shares in Dechra Pharmaceuticals (Ticker: GB:DPH).
tipranks
Paul  Sandland

Paul Sandland
Dechra Pharmaceuticals (DPH)
Chief Financial Officer

Not Ranked
Paul Sandland has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£217K
100.00%
A breakdown of Paul Sandland's holdings

Insider Roles

Dechra Pharmaceuticals
(DPH)
Chief Financial Officer
Roles that Paul Sandland holds in companies

Most Profitable Insider Trade

Stock:
Dechra Pharmaceuticals
(DPH)
Rating:Informative Sell
Date:Oct 02, 2020 - Oct 02, 2021
Return:-4.30%
The most profitable trade made by Paul Sandland

Paul Sandland's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dechra Pharmaceuticals
Oct 02, 2020
Chief Financial Officer
Uninformative Sell
50.07K
£216.66K
Success Rate for
DPH
0 out of 1 profitable transactions on
DPH
0%
Average Return for
DPH
Average return per transaction on
DPH
-4.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 02, 2020
Uninformative Sell
£50.07K
-
£1.28K
Oct 02, 2020
Informative Sell
£79.74K
-
£3.22K
-4.30%
List of latest transactions for each holding click on a transaction to see Paul Sandland's performance on stock

Paul Sandland insider profile FAQ

What is the percentage of profitable transactions made by Paul Sandland?
The percentage of profitable transactions made by Paul Sandland is ―.
    What is the average return per transaction made by Paul Sandland?
    The average return per transaction made by Paul Sandland is ―.
      What stocks does Paul Sandland hold?
      Paul Sandland holds: GB:DPH stocks.
        What was Paul Sandland’s latest transaction?
        Paul Sandland latest transaction was an Uninformative Sell of 50.07K.
          What was Paul Sandland's most profitable transaction?
          Paul Sandland’s most profitable transaction was an Informative Sell of GB:DPH stock on October 2, 2020. The return on the trade was -4.30%.
            What is Paul Sandland's role in Dechra Pharmaceuticals?
            Paul Sandland's role in Dechra Pharmaceuticals is Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.